TAMPA, Fla.--(BUSINESS WIRE)--A federal hearing underway in California challenging cannabis’ Schedule I DEA classification could lead to the current nationwide ban being declared unconstitutional, which would expand the consumer base for companies like Neutra Corp. (OTCBB:NTRR) that offer ancillary products to the marketplace.
Last month, a U.S. district judge in Sacramento granted the three-day examination into cannabis’ Schedule I DEA classification, which has classified the herb as a dangerous, illegal drug for more than 40 years. Stanford law professor Robert MacCoun told The Christian Science Monitor, “If we were starting from scratch, I very much doubt we’d put marijuana in Schedule I. But now that it’s there, it isn’t easy to move out.” The hearing has been granted because the legal counsel for two men charged with cultivating cannabis submitted expert accounts showing new scientific and medical evidence they say proves that the herb does not fit the criteria of a Schedule I drug. If the court agrees, cannabis’ Schedule I status could be ruled unconstitutional.
Last week, the district court directed the prosecution and defense in U.S. vs. Schweder to file simultaneous briefs on the constitutionality of cannabis being classified as a Schedule I controlled substance by December 17.
“This is a historic case for the U.S. cannabis industry and could be the beginning of the end for prohibition if the judge rules to reclassify the herb. It could go either way and we know the legal standards are very high. We’re cautiously optimistic,” said NTRR CEO Chris Brown. “But no matter how the judge rules, there is overwhelming momentum building in this industry as demand for better, all-natural wellness solutions grows. Either way, we’re preparing to bring cultivation and delivery systems to the U.S. cannabis marketplace.”
NTRR is working to capitalize on the nationwide wave of cannabis decriminalization and legalization by offering new technologies to cannabis consumers and producers alike. The company is working with joint venture partners to deliver new vaporizer pens with groundbreaking versatility as well as portable, self-contained indoor growing environments treated with antimicrobial coatings.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB:GWPRF), Growlife Inc. (OTCBB:PHOT) and Medbox Inc. (OTCBB:MDBX), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.